JOINN Laboratories (China) Co. Ltd. provided revenue guidance for the period January 1, 2022 to December 31, 2022. For the period, the company expects operating revenue will increase by approximately RMB 548.6344 million to RMB 851.9704 million as compared with the data in the financial statements for the corresponding period of last year, representing a year-on-year increase of approximately 36.2% to 56.2%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.85 CNY | -1.21% |
|
+6.95% | -41.59% |
07-11 | Hong Kong Stocks Rally on Chinese Regulator's Fresh Curbs on Short-Selling | MT |
07-11 | JOINN Laboratories (China) Flags Losses in H1; Shares Rise 10% | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.59% | 1.31B | |
+23.03% | 46.56B | |
+45.09% | 41.67B | |
-1.31% | 41.16B | |
+35.04% | 32.4B | |
+20.42% | 28.18B | |
-6.35% | 28.1B | |
+49.41% | 14.52B | |
+46.80% | 13.74B | |
+0.03% | 12.17B |
- Stock Market
- Equities
- 603127 Stock
- News Joinn Laboratories(China)Co.,Ltd.
- JOINN Laboratories Co., Ltd. Provides Revenue Guidance for the Period January 1, 2022 to December 31, 2022